![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 3665 |
FusionGeneSummary for AXL_CDRT1 |
![]() |
Fusion gene information | Fusion gene name: AXL_CDRT1 | Fusion gene ID: 3665 | Hgene | Tgene | Gene symbol | AXL | CDRT1 | Gene ID | 558 | 374286 |
Gene name | AXL receptor tyrosine kinase | CMT1A duplicated region transcript 1 | |
Synonyms | ARK|JTK11|Tyro7|UFO | C170RF1|C17ORF1|C17ORF1A|FBXW10B|FBXW10P1|HREP|SM25H2 | |
Cytomap | 19q13.2 | 17p12 | |
Type of gene | protein-coding | protein-coding | |
Description | tyrosine-protein kinase receptor UFOAXL oncogeneAXL transforming sequence/gene | CMT1A duplicated region transcript 1 proteinCharcot-Marie-Tooth duplicated region transcript 1F-box and WD repeat domain containing 10 pseudogene 1F-box and WD-40 domain protein 10 pseudogene 1 | |
Modification date | 20180527 | 20180329 | |
UniProtAcc | P30530 | O95170 | |
Ensembl transtripts involved in fusion gene | ENST00000301178, ENST00000359092, ENST00000594880, ENST00000593513, | ENST00000312127, ENST00000354433, ENST00000395906, ENST00000583965, | |
Fusion gene scores | * DoF score | 7 X 7 X 4=196 | 1 X 1 X 1=1 |
# samples | 7 | 1 | |
** MAII score | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: AXL [Title/Abstract] AND CDRT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AXL | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 18840707 |
Hgene | AXL | GO:0006909 | phagocytosis | 21501828 |
Hgene | AXL | GO:0032689 | negative regulation of interferon-gamma production | 18840707 |
Hgene | AXL | GO:0032825 | positive regulation of natural killer cell differentiation | 18840707 |
Hgene | AXL | GO:0035457 | cellular response to interferon-alpha | 19657094 |
Hgene | AXL | GO:0071222 | cellular response to lipopolysaccharide | 19657094 |
Hgene | AXL | GO:2000669 | negative regulation of dendritic cell apoptotic process | 19657094 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | PAAD | TCGA-HZ-A49I-01A | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000301178 | ENST00000312127 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000301178 | ENST00000354433 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000301178 | ENST00000395906 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000301178 | ENST00000583965 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000359092 | ENST00000312127 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000359092 | ENST00000354433 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000359092 | ENST00000395906 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5CDS-intron | ENST00000359092 | ENST00000583965 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
intron-intron | ENST00000594880 | ENST00000312127 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
intron-intron | ENST00000594880 | ENST00000354433 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
intron-intron | ENST00000594880 | ENST00000395906 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
intron-intron | ENST00000594880 | ENST00000583965 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5UTR-intron | ENST00000593513 | ENST00000312127 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5UTR-intron | ENST00000593513 | ENST00000354433 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5UTR-intron | ENST00000593513 | ENST00000395906 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
5UTR-intron | ENST00000593513 | ENST00000583965 | AXL | chr19 | 41737203 | + | CDRT1 | chr17 | 15469667 | - |
Top |
FusionProtFeatures for AXL_CDRT1 |
![]() |
Hgene | Tgene |
AXL | CDRT1 |
Receptor tyrosine kinase that transduces signals fromthe extracellular matrix into the cytoplasm by binding growthfactor GAS6 and which is thus regulating many physiologicalprocesses including cell survival, cell proliferation, migrationand differentiation. Ligand binding at the cell surface inducesdimerization and autophosphorylation of AXL. Following activationby ligand, ALX binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3; but also GRB2, PLCG1,LCK and PTPN11. Other downstream substrate candidates for AXL areCBL, NCK2, SOCS1 and TNS2. Recruitment of GRB2 andphosphatidylinositol 3 kinase regulatory subunits by AXL leads tothe downstream activation of the AKT kinase. GAS6/AXL signalingplays a role in various processes such as endothelial cellsurvival during acidification by preventing apoptosis, optimalcytokine signaling during human natural killer cell development,hepatic regeneration, gonadotropin-releasing hormone neuronsurvival and migration, platelet activation, or regulation ofthrombotic responses. Plays also an important role in inhibitionof Toll-like receptors (TLRs)-mediated innate immune response.{ECO:0000269|PubMed:10403904, ECO:0000269|PubMed:11484958,ECO:0000269|PubMed:12364394, ECO:0000269|PubMed:12490074,ECO:0000269|PubMed:15507525, ECO:0000269|PubMed:15733062,ECO:0000269|PubMed:1656220, ECO:0000269|PubMed:18840707}. (Microbial infection) Acts as a receptor for lassa virusand lymphocytic choriomeningitis virus, possibly through GAS6binding to phosphatidyl-serine at the surface of virion envelope.{ECO:0000269|PubMed:17005688, ECO:0000269|PubMed:21501828,ECO:0000269|PubMed:22156524, ECO:0000269|PubMed:25277499}. (Microbial infection) Acts as a receptor for Ebolavirus,possibly through GAS6 binding to phosphatidyl-serine at thesurface of virion envelope. {ECO:0000269|PubMed:22673088}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for AXL_CDRT1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for AXL_CDRT1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
AXL | TENC1, GRB2, LCK, SRC, PIK3R1, PIK3R2, GAS6, CBL, ELAVL1, TNK2, ERRFI1, HSP90AA1, HSPA1A, STUB1, FBXO25, RANBP9, TYRO3, ABL2 | CDRT1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AXL_CDRT1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for AXL_CDRT1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AXL | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | AXL | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Hgene | AXL | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Hgene | AXL | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | AXL | C0027809 | Neurilemmoma | 1 | CTD_human |
Hgene | AXL | C0206728 | Plexiform Neurofibroma | 1 | CTD_human |